Concepedia

Lawrence S. Argetsinger

LS

Statistics

Publications

30

Citations

3.3K

H-Index

22

Active since

1989

Affiliations

University of Michigan(Current)

Harvard University

Diabetes Australia

Joslin Diabetes Center

St. Jude Children's Research Hospital

Lawrence S. Argetsinger is an author at University of Michigan specializing in cell signaling, medicine, and signal transduction.

ORCID

Top concepts

Publications per year

1989–2019

30

Publications

30

Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase

Lawrence S. Argetsinger, George S. Campbell, Xianjie Yang et al. · Cell · 1993 · 992 citations · Full text

, , +7

Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy

Céline C. Berthier, Hongyu Zhang, MaryLee Schin et al. · Diabetes · 2008 · 310 citations · Full text

Growth Hormone, Interferon-γ, and Leukemia Inhibitory Factor Promoted Tyrosyl Phosphorylation of Insulin Receptor Substrate-1

Lawrence S. Argetsinger, Gene W. Hsu, Martin G. Myers et al. · Journal of Biological Chemistry · 1995 · 248 citations · Full text

Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants.

George S. Campbell, Lawrence S. Argetsinger, J N Ihle et al. · Proceedings of the National Academy of Sciences · 1994 · 226 citations · Full text

, , +22

Human SH2B1 mutations are associated with maladaptive behaviors and obesity

Michael E. Doche, Elena G. Bochukova, Hsiao-Wen Su et al. · Journal of Clinical Investigation · 2012 · 191 citations

, , +16

Rows per page

1–5 of 30